Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN251625 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Carbonic Anhydrase IX (CA9) (AA 400-459), (C-Term) antibody (Biotin)
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat, Canine
- Host
- Rabbit
- Conjugate
- Biotin
- Epitope
- AA 400-459, C-Term
- Vial size
- 0.1 mL
- Storage
- Store at 4°C in the dark.
Submitted references Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model.
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride.
Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?
Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Heijmen L, Ter Voert EG, Punt CJ, Heerschap A, Oyen WJ, Bussink J, Sweep CG, Laverman P, Span PN, de Geus-Oei LF, Boerman OC, van Laarhoven HW
Contrast media & molecular imaging 2014 May-Jun;9(3):237-45
Contrast media & molecular imaging 2014 May-Jun;9(3):237-45
Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach.
Heijmen L, Punt CJ, Ter Voert EG, de Geus-Oei LF, Heerschap A, Bussink J, Sweep CG, Zerbi V, Oyen WJ, Span PN, Boerman O, van Laarhoven HW
Investigational new drugs 2013 Aug;31(4):881-90
Investigational new drugs 2013 Aug;31(4):881-90
Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.
Sathornsumetee S, Cao Y, Marcello JE, Herndon JE 2nd, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW, Vredenburgh JJ, Rich JN
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jan 10;26(2):271-8
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jan 10;26(2):271-8
Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride.
Westbury CB, Pearson A, Nerurkar A, Reis-Filho JS, Steele D, Peckitt C, Sharp G, Yarnold JR
The British journal of radiology 2007 Nov;80(959):934-8
The British journal of radiology 2007 Nov;80(959):934-8
Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?
Kaidi A, Moorghen M, Williams AC, Paraskeva C
Gut 2007 Nov;56(11):1637-8
Gut 2007 Nov;56(11):1637-8
Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas.
Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR, Lamborn KR, Lal A
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Jan 1;13(1):68-75
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Jan 1;13(1):68-75
Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Feb;9(2):802-11
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Feb;9(2):802-11
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunofluorescence of HEK 293 cells using ABIN151877. Panel A shows CAIX-transfected cells (epitope-unmasked with SDS) and panel B shows mock transfected cells.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
